Advertisement

You are subscribed to the Drug Topics Community Pharmacists' Report. Unsubscribe here.

Drug Topics Community Pharmacists' Report

Print Subscribe

Digital Edition Subscribe

January 22, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Top article

Flu vaccine shortage elicits FDA guidance

The spike in flu cases over the past month, along with limited supplies of influenza vaccine and Tamiflu across the United States, has led FDA Commissioner Margaret Hamburg to issue guidance to pharmacists and other healthcare providers. » More

Continuing Education

New CPE Series: January activity available now

Welcome to the fifth activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The January activity covers macrovascular and microvascular complications of diabetes mellitus.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Today's Headlines

DEA proposes drug take-back rule

The Drug Enforcement Administration has proposed a rule that would finally make it legal for pharmacy retailers to collect and dispose of customers’ unwanted prescription medications. » More

Adjunct L-methylfolate may help depressive patients

Augmentation therapy with L-methylfolate may benefit patients who have been diagnosed with major depressive disorder and have had a partial or no response to SSRIs. » More

FDA warns of insomia drug, Zolpidem

In a drug safety communication, FDA has recommended that the bedtime dose of zolpidem, for the treatment of insomnia, be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving. » More

TAKE OUR SURVEY

Should state Boards of Pharmacy include more non-pharmacists on their boards to provide regulatory oversight?

- Yes
- No

Click Here to let us know.

 
Advertisement

Check these out too

FDA approves Botox for overactive bladder

New patch treats migraines

Blood clotting disorders drug approved

Web program aids anticoagulation treatment

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health may fall short despite increased pharmacy workload

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group